Prevalence of hepatitis B surface antigen and hepatitis C virus antibody and their risk factors among Guilan’s volunteer blood donors (1998-2003)

Hepatitis Monthly

Volumn 7, Issue 4, 2007, Pages 239-241

  Mansour Ghanaei, Fariborz ^a   Fallah, Mohammad Sadegh ^a   Jafarshad, Reyhaneh ^a   Joukar, Farahnaz ^a   Salari, Afshin ^a   Tavafzadeh, Ramin ^a  

^a UNIVERSITY OF GUILAN   (Iran)

Author keywords

Blood donors; Guilan; Hepatitis B; Hepatitis C; Surgery; Transfusion

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDY; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOBLOTTING; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PHLEBOTOMY; PREVALENCE; RISK FACTOR; TATTOOING; UNSAFE SEX; VIRUS NEUTRALIZATION;

EID: 70350771620     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zupanska B, Uhrynowska M, Michur H, Maslanka K, Zajko M. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang 2007; 93: 70-7.
2. Norris A, Galea G. The impact of the new tick-box questionnaire, and the personal donor interview, on donor deferrals in the East of Scotland. Transfus Med 2001; 11: 183-7.
3. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8: S18-20; discussion S1-3.
4. Anim JT, Ebrahim BH, Sathar SA. Benign disorders of the prostate: A histopathological study. Ann Saudi Med 1998; 18: 22-7.
5. Contreras M, Barbara JA, Anderson CC, Ranasinghe E, Moore C, Brennan MT, et al. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 1991; 337: 753-7.
6. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol 2006; 12: 4884-7.
7. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol 2005; 11: 4085-9.
8. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektabakhsh B. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, I.R. Iran. Hep Mon 2005; 5: 117-22.
9. Farzadegan H, Harbour C, Ala F. The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang 1979; 37: 182-6.
10. Hamidi B, Bahadori M, Mansouri S, Nategh R. Seroepidemiologic survey of hepatitis B markers in National Oil Company (NICO) heath workers in Tehran prior to mass vaccination. Arch Iran Med 2000; 3: 4-9.
11. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J 2000; 6: 1114-6.
12. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17: 1092-7.
13. Cisneros-Castolo M, Hernandez-Ruiz L, Ibarra-Robles IE, Fernandez-Garate RH, Escobedo-De La Pena J. Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. Am J Trop Med Hyg 2001; 65: 759-63.
14. Lewis-Ximenez LL, do OK, Ginuino CF, Silva JC, Schatzmayr HG, Stuver S, et al. Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil. BMC Public Health 2002; 2: 26.